1. Home
  2. HCM vs ASGN Comparison

HCM vs ASGN Comparison

Compare HCM & ASGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • ASGN
  • Stock Information
  • Founded
  • HCM 2000
  • ASGN 1985
  • Country
  • HCM Hong Kong
  • ASGN United States
  • Employees
  • HCM N/A
  • ASGN N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • ASGN Professional Services
  • Sector
  • HCM Health Care
  • ASGN Consumer Discretionary
  • Exchange
  • HCM Nasdaq
  • ASGN Nasdaq
  • Market Cap
  • HCM 2.5B
  • ASGN 2.3B
  • IPO Year
  • HCM N/A
  • ASGN 1992
  • Fundamental
  • Price
  • HCM $14.84
  • ASGN $48.58
  • Analyst Decision
  • HCM Hold
  • ASGN Hold
  • Analyst Count
  • HCM 1
  • ASGN 6
  • Target Price
  • HCM $19.00
  • ASGN $71.33
  • AVG Volume (30 Days)
  • HCM 90.6K
  • ASGN 418.1K
  • Earning Date
  • HCM 07-30-2025
  • ASGN 07-23-2025
  • Dividend Yield
  • HCM N/A
  • ASGN N/A
  • EPS Growth
  • HCM N/A
  • ASGN N/A
  • EPS
  • HCM 0.04
  • ASGN 3.52
  • Revenue
  • HCM $630,201,000.00
  • ASGN $4,019,000,000.00
  • Revenue This Year
  • HCM $14.86
  • ASGN N/A
  • Revenue Next Year
  • HCM $19.54
  • ASGN $3.20
  • P/E Ratio
  • HCM $66.84
  • ASGN $13.80
  • Revenue Growth
  • HCM N/A
  • ASGN N/A
  • 52 Week Low
  • HCM $11.51
  • ASGN $47.64
  • 52 Week High
  • HCM $21.50
  • ASGN $105.67
  • Technical
  • Relative Strength Index (RSI)
  • HCM 46.89
  • ASGN 31.58
  • Support Level
  • HCM $15.02
  • ASGN $50.53
  • Resistance Level
  • HCM $18.00
  • ASGN $55.86
  • Average True Range (ATR)
  • HCM 0.42
  • ASGN 1.37
  • MACD
  • HCM -0.04
  • ASGN -0.34
  • Stochastic Oscillator
  • HCM 31.45
  • ASGN 2.08

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About ASGN ASGN Incorporated

ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.

Share on Social Networks: